News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Indevus Pharmaceuticals, Inc. (IDEV)'s Valstar Reintroduced into Bladder Cancer Market


3/3/2009 8:14:05 AM

Mar 02, 2009 (Datamonitor via COMTEX) -- Having previously been withdrawn due to purity concerns, Indevus Pharmaceuticals' Valstar has received FDA approval for reintroduction into the bladder cancer market. The drug should be able to reclaim its original market share, although this will require an effective marketing strategy.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES